文献速递淋巴瘤

初始正电子发射断层扫描中[18F]氟脱氧葡萄糖摄取预测MALT淋巴瘤生存

Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma.
PubMed 文献 · Blood Adv · 2018-01-01

研究分析了173例活检病灶在PET上可识别的MALT淋巴瘤患者,中位随访显示PET阳性率71%,中位SUV为6.0。SUV≥10的患者后续大细胞转化率更高(20% vs 5%,P=0.035)且总生存更差(78% vs 92%,P=0.008)。FDG PET在MALT淋巴瘤初始分期之外的确切作用仍有待明确。

要点

  • 活检部位PET阳性率为71%(123/173),中位SUV为6.0(范围0.7-28.0)。
  • SUV≥10的患者后续大细胞转化率20% vs 5%(P=0.035),总生存78% vs 92%(P=0.008)。
  • PET阳性与5年总生存(96% vs 88%,P=0.229)及5年无进展生存(67% vs 56%,P=0.493)无关。

核心结论

  • SUV是总生存的独立预后因素,SUV升高与5年总生存下降相关。
  • SUV≥10的患者后续大细胞转化率更高且总生存更差。
  • FDG PET在MALT淋巴瘤初始分期之外的确切作用仍有待明确。

研究设计与样本

  • 回顾性分析2001年1月至2012年7月间173例MALT淋巴瘤患者,活检病灶在组织活检后90天内在PET上可识别。
  • PET阳性及FDG摄取强度与临床因素及患者结局进行相关性分析。

主要发现

  • 173例中活检部位PET阳性123例(71%),中位SUV为6.0(范围0.7-28.0),SUV>10.0者20例(16%)。
  • PET阳性与较高的国际预后指数相关,但与5年总生存无关(PET阴性96% vs PET阳性88%,P=0.229),与5年无进展生存亦无关(67% vs 56%,P=0.493)。
  • SUV≥10的患者后续大细胞转化率20% vs 5%(P=0.035),总生存78% vs 92%(P=0.008)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The role of [18F]fluorodeoxyglucose (FDG) positron-emission tomography (PET) in mucosa-associated lymphoid tissue (MALT) of marginal zone lymphoma remains poorly defined. We correlated initial PET with pathology, clinical factors, and outcome. From January 2001 to July 2012, 173 MALT lymphoma patients with a biopsied lesion identified on PET within 90 days of tissue biopsy were analyzed. PET positivity and intensity of FDG uptake were correlated with clinical factors and patient outcome. Among 173 accrued cases, biopsied site was PET avid in 123 patients (71%); median standardized uptake value (SUV) was 6.0 (range: 0.7-28.0), and SUV >10.0 in 20 patients (16%). PET avidity varied by organ sites. PET positivity correlated with higher International Prognostic Index, but not with 5-year overall survival (OS; 96% vs 88%, PET negative vs positive, P = .229) or 5-year progression-free survival (67% vs 56%, P = .493). SUV was an independent prognostic factor of OS, and an increased SUV was associated with a decreasing 5-year OS. Patients who presented with SUV ≥10 had a higher rate of subsequent large cell transformation (20% vs 5%, P = .035) and inferior OS (78% vs 92%, P = .008). The exact role of FDG PET in the management of MALT lymphoma, beyond initial staging, remains to be defined.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Qi S, Huang MY, Yang Y, et al. Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma. Blood Adv. 2018. PMID: 29563121. doi:10.1182/bloodadvances.2017013698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。